Influence of NT-proBNP on Efficacy of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction is a research paper published in JACC Heart Failure (2022). On theSindex it has a DataRank of 1.5. It has been cited 50 times, with 43 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.590
From this paper's citation signal
Citation Network Contribution
0.914
From 33 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 43 citers.
National Institutes of Health
Grant: R01 HL107577
National Institutes of Health
Grant: R01 HL127028
National Institutes of Health
Grant: R01 HL140731
National Institutes of Health
Grant: R01 HL149423
National Institutes of Health
Grant: U54 HL160273
FWCI
6.77
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals